Wuhan Hiteck Biological Overview

  • Status
  • Public

  • Employees
  • 1,520


  • Stock Symbol
  • 300683

Stock Symbol

  • Investments
  • 3

  • Share Price
  • $3.13
  • (As of Friday Closing)

Wuhan Hiteck Biological General Information


Wuhan Hiteck Biological Pharma Co Ltd is a biopharmaceutical manufacturing enterprise in China. The company is primarily engaged in the development, production and sale of biological products. Its product portfolio comprises rat nerve growth factor freeze-dried powder injection, injection of anti-hepatitis B transfer factor freeze-dried powder injection, thrombin and other chemicals. The company also has more than 20 kinds of products such as hepatitis B treatment drug op Heparin and hemostatic agent thrombin.

Contact Information

Ownership Status
Publicly Held
Financing Status
Primary Industry
Drug Discovery
Stock Exchange
Corporate Office
  • Hite Science and Technology Park
  • Wuhan Economic Development Zone
  • Wuhan, Hubei 430056
  • China
+86 027 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Wuhan Hiteck Biological Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.13 $2.95 $2.64 - $7.19 $409M 131M 1.72M -$0.15

Wuhan Hiteck Biological Financials Summary

In Thousands,
TTM 31-Mar-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 322,827 519,426 516,162 985,621
Revenue 83,286 85,130 102,253 95,195
EBITDA (25,534) (12,511) 5,035 7,010
Net Income (19,005) (17,078) (2,083) 4,283
Total Assets 416,697 419,159 392,338 423,199
Total Debt 8,671 9,304 14,879 17,419
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Wuhan Hiteck Biological Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Wuhan Hiteck Biological Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Wuhan Hiteck Biological‘s full profile, request access.

Request a free trial

Wuhan Hiteck Biological Investments & Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Shadong Biotechnology 27-Feb-2024 0000000000 000.00 Biotechnology
Shadong Biotechnology 22-Dec-2021 000000000 00.000 Biotechnology
CVI Pharmaceuticals 21-Jul-2021 Later Stage VC 00.000 Drug Discovery
To view Wuhan Hiteck Biological’s complete investments and acquisitions history, request access »

Wuhan Hiteck Biological Subsidiaries (1)

Company Name Industry Location Founded
Shadong Biotechnology Biotechnology Beijing, China 0000
To view Wuhan Hiteck Biological’s complete subsidiaries history, request access »

Wuhan Hiteck Biological FAQs

  • Where is Wuhan Hiteck Biological headquartered?

    Wuhan Hiteck Biological is headquartered in Wuhan, China.

  • What is the size of Wuhan Hiteck Biological?

    Wuhan Hiteck Biological has 1,520 total employees.

  • What industry is Wuhan Hiteck Biological in?

    Wuhan Hiteck Biological’s primary industry is Drug Discovery.

  • Is Wuhan Hiteck Biological a private or public company?

    Wuhan Hiteck Biological is a Public company.

  • What is Wuhan Hiteck Biological’s stock symbol?

    The ticker symbol for Wuhan Hiteck Biological is 300683.

  • What is the current stock price of Wuhan Hiteck Biological?

    As of 12-Jul-2024 the stock price of Wuhan Hiteck Biological is $3.13.

  • What is the current market cap of Wuhan Hiteck Biological?

    The current market capitalization of Wuhan Hiteck Biological is $409M.

  • What is Wuhan Hiteck Biological’s current revenue?

    The trailing twelve month revenue for Wuhan Hiteck Biological is $83.3M.

  • What is Wuhan Hiteck Biological’s annual earnings per share (EPS)?

    Wuhan Hiteck Biological’s EPS for 12 months was -$0.15.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »